Clinical Trial Update: Study of the Safety, Tolerability and Efficacy of V3381 in Patients With Diabetic Peripheral Neuropathic Pain [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety, tolerability and efficacy of V3381 in diabetic peripheral neuropathic pain has completed (status: COMPLETED).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathic Pain

Drugs mentioned

• V3381

Snippet

Sponsor: Vernalis (R&D) Ltd | Conditions: Diabetic Peripheral Neuropathic Pain | Phase 2 | Status: COMPLETED